A Review of Photodynamic Therapy for Intraocular Tumors
- *Corresponding Author:
- Tsipursky MS
Carle Physician Group and Carle Foundation Hospital
Received date: June 21, 2011; Accepted date: July 19, 2011; Published date: Augutst 02, 2011
Citation: Tsipursky MS, Churgin DS, Conway MD, Peyman GA (2011) A Review of Photodynamic Therapy for Intraocular Tumors. J Anal Bioanal Tech S1:001. doi: 10.4172/2155-9872.S1-001
Copyright: © 2011 Tsipursky MS, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Photodynamic therapy (PDT) has been used in ophthalmology for various vascular conditions affecting the retina and choroid since the late 1990’s. As of 2000, verteporfin (Visudyne; CIBA Vision Corp, Duluth, Ga) photosensitizer for ocular conditions was used in treatment of choroidal neovascularization (CNV) secondary to age-related macular degeneration (AMD), pathologic myopia, and presumed ocular histoplasmosis syndrome